Eversource Faces Analyst Skepticism Before Q3 Numbers
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Eversource Energy reports Q3 results on November 4, carrying a stock that has recovered 7% over the past month but still faces a divided analyst community and a short interest position that jumped 15% in a week.
The positioning is not extreme, but it shifted notably in October. Short interest climbed from around 8.5 million shares to above 11 million between October 23 and October 26, before pulling back to 10.5 million on October 29. That leaves SI at 2.8% of the free float, low by most standards, but the velocity of the move is worth noting. Borrowing costs rose 22% over the week to 0.45%, still cheap in absolute terms. Availability is abundant at over 5,600%, meaning the lending pool is nowhere near exhausted. Options positioning leans cautiously defensive, with the put/call ratio at 1.24, modestly above its 20-day average of 1.18, without suggesting panic. The stock gained 1.6% over the past week, slightly behind the 2.1% median move for its closest utility peers including SO, LNT and DUK.
The analyst picture is more cautious than the recent price recovery implies. JP Morgan trimmed its target to $68 from $73 on October 19, maintaining its Underweight rating, which now sits almost exactly at the current share price of $68.55. That's a meaningful signal from a bellwether firm: the stock is priced at the low end of the Street's range. HSBC initiated coverage on October 22 with a Hold and a $70 target, adding another neutral voice. The consensus target of $71.69 offers modest upside from here. The bear argument centres on transmission ROE cuts, a pending refund for over-earning in electric transmission, the slow progress on the Aquarion Water sale, and regulatory friction in Connecticut. Against that, Wells Fargo remains the most constructive voice with an Overweight and a $76 target, pointing to the company's equity issuance programme as a credit-strengthening measure. Eversource plans roughly $800 million in equity in late 2027, plus up to $1.1 billion through its ATM through 2029, which does protect the balance sheet but puts downward pressure on earnings per share and dividend growth along the way.
Insider activity over the 90 days to August 25 leaned negative, with net open-market sales of around $703,000. None of the trades were large relative to the company's $25.8 billion market cap, and one director made a small purchase of 750 shares in May. The pattern reflects caution rather than conviction in either direction.
The November 4 print will test whether Eversource can offer enough clarity on its regulatory disputes and asset disposal timeline to close the gap between where the stock trades and where the more skeptical analysts have set their targets.
Stocks in this article
See the live data behind this article on ORTEX.
Open ES on ORTEX →How this article was generated
- Generated
- 1 Nov 2026, 04:14
- Data as of
- 1 Nov 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.